RTTNews | Dec 1, 2021 08:38AM EST

08:37 Wednesday, December 1, 2021 (RTTNews) - Moleculin Gets FDA Allowance To Begin A Phase 1 Study Of WP1122 For Treatment Of Glioblastoma Multiforme; Stock Up

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved